Review of IDH-Mutant Glioma Management

Dates and Times

Start: 5/15/2026 8:00 AM
End: 5/15/2026 9:00 AM

Objectives

1. Review modern molecular classifications in glioma diagnosis
2. Explain the biology of IDH mutations in diffuse gliomas
3. Discuss implications for prognosis and treatment
4. Understand emerging targeted therapies and future directions

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.